Blog

What if cancer treatment could be virtually tested before it’s given to a patient? That’s the hope of Molecular Digital Twins.

What are Molecular Digital Twins?

In precision oncology, a Molecular Digital Twin (sometimes called digital twin or molecular twin) is a high-dimensional, computational in silico (virtual) model of an individual patient’s unique biological state. Unlike static risk-scoring tools or single-marker diagnostic tests, a Molecular Digital Twin integrates multimodal, multiscale biological data into an adaptive mathematical and machine-learning framework that continuously updates to simulate disease trajectories and predict responses to specific therapies.

How can they help cancer patients?

In oncology, a Molecular Digital Twin approach allows care to move from a reactive, “one-size-fits-all” paradigm to a proactive, continuous, and highly personalized model. 

By creating a dynamic, computational replicate of a patient’s biological state, a Digital Twin helps cancer patients in four primary ways:

1. Virtually testing treatment strategies to identify options most likely to work.
A Digital Twin could allow doctors to virtually test different treatment options and identify which therapies are most likely to work for a particular patient, potentially reducing the need for trial and error.

2. Detecting treatment resistance earlier, potentially before it becomes visible on standard scans.
By continuously analyzing blood tests and other biomarkers, a Digital Twin could potentially identify signs that a treatment isn’t working weeks or months earlier, giving doctors more time to respond.

3. Optimizing treatment timing and sequencing as a patient’s disease evolves.
Digital Twins could model how a patient’s cancer is likely to evolve and help doctors determine when to switch therapies, perform surgery, or introduce another intervention.

4. Balancing treatment effectiveness with quality of life by including both tumor dynamics and patient-centered factors.
This could help researchers and clinicians explore treatment approaches that effectively target cancer while minimizing unnecessary toxicity.

Advancing Conversations Around Molecular Digital Twins

Experts will explore the potential impact of Molecular Digital Twins on some of the most challenging areas of cancer care, including colorectal cancer and more, at the NFCR Global Summit, and you can be a part of the conversation. Learn more about this event today.

If you would like to hear more about Molecular Digital Twins, give our team a call at: 1-800-321-CURE (2873).